Menu Search
Equities

Beijing Chunlizhengda Medical Instruments Co Ltd

1858:HKG.HS

Beijing Chunlizhengda Medical Instruments Co Ltd

Actions
  • Price (HKD)8.24
  • Today's Change-0.26 / -3.06%
  • Shares traded831.75k
  • 1 Year change-40.55%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Beijing Chunlizhengda Medical Instruments Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of implantable orthopedic medical devices. The Company's main products are joint prosthesis products and spine implant products. The joint prosthesis products cover four human joints: hip, knee, shoulder and elbow. The spine implant products are a full range of product combinations of spinal internal fixation systems. The Company's products are exported to Asia, South America, Africa, Oceania, Europe and other countries and regions.

  • Revenue in CNY (TTM)924.65m
  • Net income in CNY158.35m
  • Incorporated1998
  • Employees1.23k
  • Location
    Beijing Chunlizhengda Medical Instruments Co Ltd20F, Tower A, Gaohe Lanfeng MansionNo. 98, East Third Ring South RoadBEIJING 101100ChinaCHN
  • Phone+86 1 087361998
  • Fax+86 1 080561690
  • Websitehttp://www.clzd.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.